In contrast, supplementation with bFGF showed a statistical difference with ARS (174.87 μg/ml) with respect to OM or OM + EGF, but the number of mineralized nodules were fewer than OM, suggesting an inhibitory effect (Fig. 3e). The gene discussed is FGF2; the disease is ocular melanoma.